CME Information

Accreditation

The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™

The American College of Surgeons designates this live activity for a maximum of 16.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program.

Those claiming CMEs must complete the evaluation form by March 22, 2025.

Complete CME Evaluation

Program Objectives

Understanding combat casualty care in large-scale combat operations
Addressing the evolutions and revolutions of battlefield medicine from 20th- and 21st-century wars
Discussing international perspectives
Assessing tactical, operational, and strategic trauma care for large-scale combat operations
Understanding the importance of prehospital care
Learning to improve communication for better care
Learning about the importance of mitigating the Walker Dip
Discussing the importance of a globally integrated trauma system for large scale combat operations and beyond
Addressing the importance of leadership
Addressing the need to preserve the lessons learned for the future of combat casualty care

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible Company

The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

Speaker Disclosures

Ievgenii Antoniuk—Nothing to disclose

John Armstrong—Nothing to disclose

Andrew Beckett—Nothing to disclose

Doug Bowley—Nothing to disclose

Mark Bowyer—Nothing to disclose

Matthew Bradley—Nothing to disclose

Jeremy Cannon—Nothing to disclose

Alan Chambers—Nothing to disclose

Peter Chiarelli—Nothing to disclose

Warren Dorlac—American College of Surgeons, Vice Chair, Committee on Trauma, Travel Expenses; NAEMT, Medical Director PreHospital Trauma, Travel Expenses; Zoll Medical, Speaker to Zoll military group, Honorarium; Thornhill Medical, Speaker, Honorarium; Cellphire Therapeutics, Advisor, Honorarium; Zibrio, Investor, start-up; Decisio Health, Investor, start-up; Aspen Medical, Ukraine, Co-coordinator DoD-funded, Salary support

Brian Eastridge—Nothing to disclose

Eric Elster—Nothing to disclose

Steven Flaherty—Nothing to disclose

Paul Friedrichs—Nothing to disclose

Elon Glassberg—Nothing to disclose

Kirby Gross—Nothing to disclose

Jennifer Gurney—Nothing to disclose

John Holcomb—Decision Health, Founder and Board of Directors, Stock options; Qin Flow,Board of Directors, Stock options; Hemostatics, Zibrio, Board of Directors, Stock options; CCJ Medical, Board of Directors, Equity; WFIRM, Consultant, Consult Fee; Aspen Medical, Consultant, Consult Fee; Geneva Foundation, Consultant, Consult Fee; UT Houston, Coinventor of a junctional tourniquet, Royalty

Donald Jenkins—Nothing to disclose

Jeffrey Kerby—Nothing to disclose

Mary Margaret Knudson—Nothing to disclose

Ari Leppaniemi—Nothing to disclose

Robert Mabry—Nothing to disclose

Emily Mayhew—Nothing to disclose

Austin Miller—Nothing to disclose

Travis Polk—Nothing to disclose

Todd Rasmussen—Prytime Medical, Stock Options; Perfusion Medical, Stock Options; Humacyte, Funding to Mayo Clinic for conduct of clinical research

Valerie Sams—Nothing to disclose

Martin Schreiber—Haeomonetics, Grantee and Consultant, Grant and Consult Fees; CSL Behring, Grantee and Consultant, Grant and Consult Fees; Octapharma, Consultant, Consult Fee; Tricol, Consultant, Consult Fee; Trauma Textbook-Mattox, Moore, Feliciano, Editor, Editorial Fees

Andreas Stettbacher—Nothing to disclose

Ronald Stewart—Nothing to disclose

Michael Sutherland—Nothing to disclose

Matthew Tadlock—Nothing to disclose

Nigel Tai—Nothing to disclose

Jonathan Woodson—Nothing to disclose

Continuing Medical Education Credit Information